These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 381707)

  • 21. Specific distribution of R factors in Serratia marcescens strains isolated from hospital infections.
    Schaefler S; Winter J; Catelli A; Greene J; Toharski B
    Appl Microbiol; 1971 Sep; 22(3):339-43. PubMed ID: 4940874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].
    Jotzoff M
    Med Klin; 1978 Jun; 73(24):914-7. PubMed ID: 661734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of R factors in Serratia marcescens strains isolated from the "Hospital Universitario de Caracas".
    Rodríguez Lemoine V; de Ramírez Y; Pedroza R
    Acta Cient Venez; 1983; 34(3-4):228-32. PubMed ID: 6399968
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.
    Potel G; Caillon J; Fantin B; Raza J; Le Gallou F; Lepage JY; Le Conte P; Bugnon D; Baron D; Drugeon H
    Antimicrob Agents Chemother; 1991 Jan; 35(1):111-6. PubMed ID: 2014965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Bacteriocin (marcescin) typing of Serratia marcescens. II. The distribution of Serratia marcescens in hospital and its isolated cases by bacteriocin (marcescin) typing (author's transl)].
    Nasu M
    Kansenshogaku Zasshi; 1978 Jun; 52(6):183-9. PubMed ID: 101627
    [No Abstract]   [Full Text] [Related]  

  • 26. A laboratory assessment of the activities of four aminoglycosides.
    Schrire L; Robinson RG; Koornhof HJ
    S Afr Med J; 1984 Jun; 65(23):922-4. PubMed ID: 6427946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinico-bacteriological study of 20 Serratia marcescens infections treated with amikacin].
    Pérez González F; Prendes Peláez P; Meana Fonseca JL; Martín Alvarez R
    Rev Clin Esp; 1981 Jun 15-30; 161(5-6):327-34. PubMed ID: 7027369
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Dec; 22(6):1058-63. PubMed ID: 4944804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and susceptibility of serratia marcescens in a large general hospital over an 8-year period.
    Hejazi A; Aucken HM; Falkiner FR
    J Hosp Infect; 2000 May; 45(1):42-6. PubMed ID: 10833342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An outbreak of multidrug-resistant Serratia marcescens: the importance of continuous monitoring of nosocomial infections.
    Šiširak M; Hukić M
    Acta Med Acad; 2013; 42(1):25-31. PubMed ID: 23735063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ["In vitro" activity of gentamicin, sisomicin and tobramycin against "pseudomonas aeruginosa" strains from hospital sources (author's transl)].
    Campello C; Crevatin E
    Ann Sclavo; 1977; 19(3):437-45. PubMed ID: 415672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serratia marcescens infections in a hospital: typing of isolated strains].
    Yde M
    Arch Belg; 1989; 47(5-6):189-210. PubMed ID: 2700064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmid prevalence in antibiotic resistant Serratia marcescens.
    Llanes C; Michel-Briand Y; Bailly C; Grimont F
    J Chemother; 1989 Jul; 1(4 Suppl):311-2. PubMed ID: 16312416
    [No Abstract]   [Full Text] [Related]  

  • 34. [Urinary tract infections due to Serratia marcescens. I. Antimicrobial susceptibility patterns of clinical isolates of Serratia marcescens (author's transl)].
    Igari J; Kosakai N
    Jpn J Antibiot; 1977 Oct; 30(10):840-6. PubMed ID: 338940
    [No Abstract]   [Full Text] [Related]  

  • 35. Epidemiological markers of Serratia marcescens isolates causing nosocomial infections in Spain (1981-1991).
    Boquete T; Vindel A; Martin-Bourgon C; Azañedo L; Sáez-Nieto JA
    Microbiologia; 1996 Dec; 12(4):607-12. PubMed ID: 9018695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes over a period of five years of Serratia marcescens endemia at the Centre Hospitalier de Strasbourg].
    Minck R; Le Minor S; Dammron A; Reeb E; Benazet F; Martin L; Lapeyre B
    Ann Biol Clin (Paris); 1983; 41(1):51-4. PubMed ID: 6346963
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serratia marcescens infection in intensive care units (author's transl)].
    Freitag V; Morr-Strathmann U; Caselitz FH; Lawin P
    Prakt Anaesth; 1975 Jun; 10(3):119-25. PubMed ID: 787963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of epidemiologic markers of nosocomial Serratia marcescens isolates with special reference to the Grimont biotyping system.
    Sifuentes-Osornio J; Ruiz-Palacios GM; Gröschel DH
    J Clin Microbiol; 1986 Feb; 23(2):230-4. PubMed ID: 3517048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular epidemiology of Serratia marcescens in a hospital.
    Sekiguchi J; Fujino T; Kuroda E; Konosaki H; Nishimura H; Saruta K; Kawana A; Yamanishi F; Kudo K; Kondo T; Yazaki Y; Kuratsuji T; Kirikae T
    Jpn J Infect Dis; 2004 Apr; 57(2):78-80. PubMed ID: 15118217
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serratia marcescens ("B. prodigiosus"), the germ of hospital infections].
    Modde H
    Rev Med Suisse Romande; 1974 Apr; 94(4):325-32. PubMed ID: 4596928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.